These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7525978)

  • 1. Prognostic significance of insulin-like growth factor-binding protein expression in axillary lymph node-negative breast cancer.
    Yee D; Sharma J; Hilsenbeck SG
    J Natl Cancer Inst; 1994 Dec; 86(23):1785-9. PubMed ID: 7525978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of insulin-like growth factor-binding protein-3 messenger RNA with protein expression in primary breast cancer tissues: detection of higher levels in tumors with poor prognostic features.
    Rocha RL; Hilsenbeck SG; Jackson JG; Lee AV; Figueroa JA; Yee D
    J Natl Cancer Inst; 1996 May; 88(9):601-6. PubMed ID: 8609661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between insulin-like growth factors and their binding proteins and other prognostic indicators in breast cancer.
    Yu H; Levesque MA; Khosravi MJ; Papanastasiou-Diamandi A; Clark GM; Diamandis EP
    Br J Cancer; 1996 Oct; 74(8):1242-7. PubMed ID: 8883411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor binding protein-3 and insulin receptor substrate-1 in breast cancer: correlation with clinical parameters and disease-free survival.
    Rocha RL; Hilsenbeck SG; Jackson JG; VanDenBerg CL; Weng Cn; Lee AV; Yee D
    Clin Cancer Res; 1997 Jan; 3(1):103-9. PubMed ID: 9815544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of insulin-like growth factor binding proteins (IGFBPs) by ligand blotting in breast cancer tissues.
    McGuire SE; Hilsenbeck SG; Figueroa JA; Jackson JG; Yee D
    Cancer Lett; 1994 Feb; 77(1):25-32. PubMed ID: 7512885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of insulin-like growth factor-binding protein (IGFBP) expression by breast cancer cells: use of IGFBP-1 as an inhibitor of insulin-like growth factor action.
    McGuire WL; Jackson JG; Figueroa JA; Shimasaki S; Powell DR; Yee D
    J Natl Cancer Inst; 1992 Sep; 84(17):1336-41. PubMed ID: 1379645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of insulin-like growth factor binding proteins in human breast cancer correlates with estrogen receptor status.
    Figueroa JA; Jackson JG; McGuire WL; Krywicki RF; Yee D
    J Cell Biochem; 1993 Jun; 52(2):196-205. PubMed ID: 7690042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5 expression in breast cancer.
    Mita K; Zhang Z; Ando Y; Toyama T; Hamaguchi M; Kobayashi S; Hayashi S; Fujii Y; Iwase H; Yamashita H
    Jpn J Clin Oncol; 2007 Aug; 37(8):575-82. PubMed ID: 17675285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor-binding protein-3 and breast cancer survival.
    Yu H; Levesque MA; Khosravi MJ; Papanastasiou-Diamandi A; Clark GM; Diamandis EP
    Int J Cancer; 1998 Dec; 79(6):624-8. PubMed ID: 9842972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of insulin-like growth factor-binding-protein-1, 2, 3, 4, 5, and 6: synthesis, secretion, and gene expression in estrogen receptor-negative human breast carcinoma cells.
    Sheikh MS; Shao ZM; Hussain A; Clemmons DR; Chen JC; Roberts CT; LeRoith D; Fontana JA
    J Cell Physiol; 1993 Jun; 155(3):556-67. PubMed ID: 7684042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complex pattern of insulin-like growth factor binding protein expression in primary rat osteoblast enriched cultures: regulation by prostaglandin E2, growth hormone, and the insulin-like growth factors.
    McCarthy TL; Casinghino S; Centrella M; Canalis E
    J Cell Physiol; 1994 Jul; 160(1):163-75. PubMed ID: 7517403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor-I (IGF-I) and retinoic acid modulation of IGF-binding proteins (IGFBPs): IGFBP-2, -3, and -4 gene expression and protein secretion in a breast cancer cell line.
    Adamo ML; Shao ZM; Lanau F; Chen JC; Clemmons DR; Roberts CT; LeRoith D; Fontana JA
    Endocrinology; 1992 Oct; 131(4):1858-66. PubMed ID: 1382963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversible effects of cessation and recommencement of thyroxine treatment on insulin-like growth factors (IGFs) and IGF-binding proteins in patients with total thyroidectomy.
    Miell JP; Zini M; Quin JD; Jones J; Portioli I; Valcavi R
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1507-12. PubMed ID: 7525638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor binding proteins in human breast cancer tissue.
    Pekonen F; Nyman T; Ilvesmäki V; Partanen S
    Cancer Res; 1992 Oct; 52(19):5204-7. PubMed ID: 1382838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heat shock protein hsp70 in patients with axillary lymph node-negative breast cancer: prognostic implications.
    Ciocca DR; Clark GM; Tandon AK; Fuqua SA; Welch WJ; McGuire WL
    J Natl Cancer Inst; 1993 Apr; 85(7):570-4. PubMed ID: 8455204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of the potential suppressor gene IGFBP-rP1 in human breast cancer is associated with inactivation of the retinoblastoma protein, cyclin E overexpression and increased proliferation in estrogen receptor negative tumors.
    Landberg G; Ostlund H; Nielsen NH; Roos G; Emdin S; Burger AM; Seth A
    Oncogene; 2001 Jun; 20(27):3497-505. PubMed ID: 11429696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor binding proteins 1 and 3 and breast cancer outcomes.
    Goodwin PJ; Ennis M; Pritchard KI; Trudeau ME; Koo J; Hartwick W; Hoffma B; Hood N
    Breast Cancer Res Treat; 2002 Jul; 74(1):65-76. PubMed ID: 12150454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor-binding protein-3 production by MCF-7 breast cancer cells: stimulation by retinoic acid and cyclic adenosine monophosphate and differential effects of estradiol.
    Martin JL; Coverley JA; Pattison ST; Baxter RC
    Endocrinology; 1995 Mar; 136(3):1219-26. PubMed ID: 7532580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IGFBP-3 gene expression and estrogen receptor status in human breast carcinoma.
    Shao ZM; Sheikh MS; Ordonez JV; Feng P; Kute T; Chen JC; Aisner S; Schnaper L; LeRoith D; Roberts CT
    Cancer Res; 1992 Sep; 52(18):5100-3. PubMed ID: 1381277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor binding protein (IGFBP)-3 levels in conditioned media of Hs578T human breast cancer cells are post-transcriptionally regulated.
    Oh Y; Müller HL; Pham H; Lamson G; Rosenfeld RG
    Growth Regul; 1993 Mar; 3(1):84-7. PubMed ID: 7683543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.